ai3Bio Inc

ai3Bio is a biotechnology company developing therapies for autoimmune disease by targeting pathogenic T cells at their source. It combines AI-enabled analysis of diseased tissue with two therapeutic platforms: STARx, which uses lipid nanoparticles to deliver mRNA that prompts disease-causing cells to self-destruct, and T Deplete, an antibody approach that recruits the body’s immune cells to clear them. Its goal is to move care beyond immune suppression toward lasting remission.